HeartBeam (BEAT) Change in Accured Expenses (2020 - 2026)
HeartBeam's (BEAT) quarterly Change in Accured Expenses came in at -$788000.0 in Q2 2026, down 506.19% year-over-year from $194000.0 in Q2 2025, and down 1213.33% quarter-over-quarter from -$60000.0 in Q1 2026.
Powered by 
Analysis
HeartBeam (BEAT) Change in Accured Expenses (2020 - 2026) Analysis & Trends
HeartBeam (BEAT) has reported Change in Accured Expenses for 7 consecutive years, with -$788000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 506.19% year-over-year to -$788000.0 in Q2 2026; TTM through Jun 2026 was $528000.0, a 43.48% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 256.54% from the prior year.
- Change in Accured Expenses was -$788000.0 for Q2 2026 at HeartBeam, down from -$60000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $761000.0 in Q4 2025 and troughed at -$1.7 million in Q2 2023.
- A 5-year average of $120444.4 and a median of $225000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses surged 38300.0% in 2022 and sank 783.2% in 2023, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $733000.0 in 2022, then sank by 76.13% to $175000.0 in 2023, then plunged by 233.71% to -$234000.0 in 2024, then jumped by 425.21% to $761000.0 in 2025, then plunged by 203.55% to -$788000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$788000.0 (Q2 2026), -$60000.0 (Q1 2026), and $761000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 50.56 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | -788,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -788,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | 761,000.00 |
| Sep 30, 2025 | 615,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -234,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Jun 30, 2024 | 307,000.00 |
| Mar 31, 2024 | -97,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 448,000.00 |
| Jun 30, 2023 | -1.75 Mn |
| Mar 31, 2023 | 655,000.00 |
| Dec 31, 2022 | 733,000.00 |
| Sep 30, 2022 | 162,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 382,000.00 |
| Dec 31, 2021 | -567,000.00 |
| Sep 30, 2021 | 138,000.00 |